| BMPR2 mutations and survival in pulmonary arterial hypertension: an individual participant data meta-analysis JDW Evans, B Girerd, D Montani, XJ Wang, N Galiè, ED Austin, G Elliott, ... The lancet Respiratory medicine 4 (2), 129-137, 2016 | 389 | 2016 |
| Luteolin alleviates cognitive impairment in Alzheimer’s disease mouse model via inhibiting endoplasmic reticulum stress-dependent neuroinflammation J Kou, J Shi, Y He, J Hao, H Zhang, D Luo, J Song, Y Yan, X Xie, G Du, ... Acta Pharmacologica Sinica 43 (4), 840-849, 2022 | 70 | 2022 |
| Hypermethylation of BMPR2 Promoter Occurs in Patients with Heritable Pulmonary Arterial Hypertension and Inhibits BMPR2 Expression D Liu, Y Yan, JW Chen, P Yuan, XJ Wang, R Jiang, L Wang, QH Zhao, ... American journal of respiratory and critical care medicine 196 (7), 925-928, 2017 | 57 | 2017 |
| DNA methyltransferase 3B deficiency unveils a new pathological mechanism of pulmonary hypertension YI Yan, YY He, X Jiang, Y Wang, JW Chen, JH Zhao, J Ye, TY Lian, ... Science Advances 6 (50), eaba2470, 2020 | 46 | 2020 |
| Spermine promotes pulmonary vascular remodelling and its synthase is a therapeutic target for pulmonary arterial hypertension YY He, Y Yan, X Jiang, JH Zhao, Z Wang, T Wu, Y Wang, SS Guo, J Ye, ... European Respiratory Journal 56 (5), 2020 | 43 | 2020 |
| Metabolic reprogramming of the urea cycle pathway in experimental pulmonary arterial hypertension rats induced by monocrotaline HK Zheng, JH Zhao, Y Yan, TY Lian, J Ye, XJ Wang, Z Wang, ZC Jing, ... Respiratory Research 19, 1-12, 2018 | 34 | 2018 |
| Elevated levels of plasma transforming growth factor-β1 in idiopathic and heritable pulmonary arterial hypertension Y Yan, XJ Wang, SQ Li, SH Yang, ZC Lv, LT Wang, YY He, X Jiang, ... International Journal of Cardiology 222, 368-374, 2016 | 32 | 2016 |
| Association of rare PTGIS variants with susceptibility and pulmonary vascular response in patients with idiopathic pulmonary arterial hypertension XJ Wang, XQ Xu, K Sun, KQ Liu, SQ Li, X Jiang, QH Zhao, L Wang, ... JAMA cardiology 5 (6), 677-684, 2020 | 31 | 2020 |
| Targeting the chemokine network in atherosclerosis Y Yan, M Thakur, EPC van der Vorst, C Weber, Y Döring Atherosclerosis 330, 95-106, 2021 | 29 | 2021 |
| Curcumin reduces cognitive deficits by inhibiting neuroinflammation through the endoplasmic reticulum stress pathway in apolipoprotein E4 transgenic mice J Kou, M Wang, J Shi, H Zhang, X Pu, S Song, C Yang, Y Yan, Y Doring, ... ACS omega 6 (10), 6654-6662, 2021 | 29 | 2021 |
| G-protein coupled receptor targeting on myeloid cells in atherosclerosis EPC Van der Vorst, LJF Peters, M Müller, S Gencer, Y Yan, C Weber, ... Frontiers in pharmacology 10, 451850, 2019 | 18 | 2019 |
| The role of glutamine and glutaminase in pulmonary hypertension S Wang, Y Yan, WJ Xu, SG Gong, XJ Zhong, QY An, YL Zhao, JM Liu, ... Frontiers in Cardiovascular Medicine 9, 838657, 2022 | 16 | 2022 |
| Circulating plasma metabolomic profiles differentiate rodent models of pulmonary hypertension and idiopathic pulmonary arterial hypertension patients JH Zhao, YY He, SS Guo, Y Yan, Z Wang, J Ye, JL Zhang, Y Wang, ... American Journal of Hypertension 32 (11), 1109-1117, 2019 | 16 | 2019 |
| Identification of hypoxia induced metabolism associated genes in pulmonary hypertension YY He, XM Xie, HD Zhang, J Ye, S Gencer, EPC van der Vorst, Y Döring, ... Frontiers in pharmacology 12, 753727, 2021 | 14 | 2021 |
| Methyl salicylate 2-O-β-d-lactoside alleviates the pathological progression of pristane-induced systemic lupus erythematosus-like disease in mice via suppression … YY He, Y Yan, HF Zhang, YH Lin, YC Chen, Y Yan, P Wu, JS Fang, ... Drug Design, Development and Therapy, 3183-3196, 2016 | 13 | 2016 |
| Protein O-GlcNAcylation in cardiovascular diseases H Wang, Y Wang, Y Zhou, Y Wei, Y Yan, Z Zhang, Z Jing Acta Pharmacologica Sinica 44 (1), 8-18, 2023 | 12 | 2023 |
| Cornuside Is a Potential Agent against Alzheimer’s Disease via Orchestration of Reactive Astrocytes JZ Shi, XM Zheng, YF Zhou, LY Yun, DM Luo, JJ Hao, PF Liu, WK Zhang, ... Nutrients 14 (15), 3179, 2022 | 12 | 2022 |
| Plasma metabolomics in the perioperative period of defect repair in patients with pulmonary arterial hypertension associated with congenital heart disease Y He, Y Yan, J Chen, S Liu, L Hua, X Jiang, X Xu, D Lu, Z Jing, F Yan, ... Acta Pharmacologica Sinica 43 (7), 1710-1720, 2022 | 12 | 2022 |
| Implication of proliferation gene biomarkers in pulmonary hypertension Y Yan, R Jiang, P Yuan, L Wen, XB Pang, ZC Jing, YY He, ZY Han Animal Models and Experimental Medicine 4 (4), 369-380, 2021 | 11 | 2021 |
| BMPR2 mutations and survival in pulmonary arterial hypertension: an individual participant data meta-analysis. Lancet Respir Med. 2016; 4 (2): 129–37 JDW Evans, B Girerd, D Montani, XJ Wang, N Galie, ED Austin, G Elliott, ... | 11 | |
